Pure Global

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study - Trial NCT06323291

Access comprehensive clinical trial information for NCT06323291 through Pure Global AI's free database. This Phase 1 trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Pancreatic Cancer. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06323291
Phase 1
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06323291
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

Study Focus

Pancreatic Cancer

Coaching Sessions

Interventional

behavioral

Sponsor & Location

H. Lee Moffitt Cancer Center and Research Institute

Tampa, United States of America

Timeline & Enrollment

Phase 1

Apr 01, 2024

Mar 01, 2026

20 participants

Primary Outcome

Recruitment Rate,Participant Acceptance of the Digital Health Coaching Program,Participant Ease of Usability of the Digital Health Coaching Program,Feasibility of Utilizing the Digital Health Coaching Program

Summary

This Pilot Study will evaluate a 12-week pilot program that offers digital health coaching
 for individuals with pancreatic cancer and their caregivers.

ICD-10 Classifications

Malignant neoplasm of pancreas
Malignant neoplasm: Pancreas, unspecified
Malignant neoplasm: Head of pancreas
Malignant neoplasm: Tail of pancreas
Malignant neoplasm: Other parts of pancreas

Data Source

ClinicalTrials.gov

NCT06323291

Non-Device Trial